Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
European Psychiatry April 1, 2021 Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos et al. 1 citation
Promising findings suggest psilocybin, a potent hallucinogen, may offer relief for obsessive-compulsive disorder. One open-label clinical trial observed acute reductions in obsessive-compulsive symptoms, sparking interest across psychology and psychiatry. This initial data is encouraging for medicine and clinical psychology, prompting further rigorous clinical trials. These investigations aim to solidify psilocybin's potential in mental health research topics, exploring new therapeutic avenues for psychotherapists and advancing psychedelics and drug studies.